Adenocarcinomas associated with perianal fistulae in Crohn's disease have a rectal, not an anal, immunophenotype

Pathology

Volumn 43, Issue 1, 2011, Pages 36-39

  Nishigami, Takashi ^a   Kataoka, Tatsuki R ^a   Ikeuchi, Hiroki ^a   Torii, Ikuko ^a   Sato, Ayuko ^a   Tomita, Naohiro ^a   Tsujimura, Tohru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

CK20; Crohn's disease; MUC2; Perianal adenocarcinoma; Perianal fistula

Indexed keywords

EID: 80052187746     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e328340e4d6     Document Type: Article

References (25)

1. Fenger C, Frisch M, Marti MC, et al. Tumours of the anal canal. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumors. Pathology and genetics. Tumours of the digestive system. Lyon: IARC Press, 2000;145-55.
2. Thomas M, Bienkowski R, Vandermeer TJ, et al. Malignant transformation in perianal fistulas of Crohn's disease: a systematic review of literature. J Gastrointest Surg 2010; 14: 66-73.
3. Lightdale CJ, Sternberg SS, Posner G, et al. Carcinoma complicating Crohn's disease: report of seven cases and review of the literature. Am J Med 1975; 59: 2628.
4. Nielsen OH, Rogler G, Hahnloser D, et al. Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol 2009; 6: 92-106.
5. Fenger C, Filipe MI. Pathology of the anal glands with special reference to their mucinous histochemistry. Acta Path Microbiol Scand (Sect A) 1977; 85: 273-85. (Pubitemid 8093100)
6. Wellman KF. Case reports - Adenocarcinoma of anal duct origin. Can J Surg 1962; 5: 311-8.
7. Lee SH, Zucker M, Sato T. Primary adenocarcinoma of an anal gland with secondary perianal fistulas. Hum Pathol 1981; 12: 1034-6. (Pubitemid 12253393)
8. Wong NA, Shirazi T, Hamer-Hodges DW, et al. Adenocarcinoma arising within a Crohn's-related anorectal fistula: a form of anal gland carcinoma? Histopathology 2002; 40: 302-4. (Pubitemid 34227127)
9. Ball CS, Wujanto R, Haboubi NY, et al. Carcinoma in anal Crohn's disease. J R Soc Med 1988; 81: 21-9.
10. Prioleau PG, Allen MS, Roberts T. Perianal mucinous adenocarcinoma. Cancer 1977; 39: 1295-9. (Pubitemid 8081208)
11. Gum JR. Mucin genes and the proteins they encode: structure, diversity, and regulation. Am J Respir Cell Mol Biol 1992; 7: 557-64.
12. Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002; 38: 758-63. (Pubitemid 34280319)
13. Traber PG, Silberg DG. Intestine-specific gene transcription. Annu Rev Physiol 1996; 58: 275-97. (Pubitemid 26106722)
14. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 2003; 27: 303-10. (Pubitemid 36245795)
15. Kuan SF, Montag AG, Hart J, et al. Differential expression of mucin genes in mammary and extramammary Paget's disease. Am J Surg Pathol 2001; 25: 1469-77. (Pubitemid 33096960)
16. Hobbs CM, Lowry MA, Owen D, et al. Anal gland carcinoma. Cancer 2001; 92: 2045-9. (Pubitemid 32973312)
17. Kuroda N, Tanida N, Ohara M, et al. Anal canal adenocarcinoma with MUC5AC expression suggestive of anal gland origin. Med Mol Morphol 2007; 40: 50-3. (Pubitemid 46475020)
18. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004; 23: 77-99. (Pubitemid 38221597)
19. Baba Y, Nosho K, Shima K, et al. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin Cancer Res 2009; 15: 4665-73.
20. Bataille F, Klebl F, Rümmele P, et al. Morphological characterisation of Crohn's disease fistulae. Gut 2004; 53: 1314-21. (Pubitemid 39120119)
21. Bataille F, Rohrmeier C, Bates R, et al. Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflamm Bowel Dis 2008; 14: 1514-27.
22. Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol 2008; 14: 2662-9.
23. Sjödahl RI, Myrelid P, Söderholm JD. Anal and rectal cancer in Crohn's disease. Colorectal Dis 2003; 5: 490-5. (Pubitemid 37080660)
24. Gaertner WB, Hagerman GF, Finne CO, et al. Fistula-associated anal adenocarcinoma: good results with aggressive therapy. Dis Colon Rectum 2008; 51: 1061-7.
25. Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet 2010; 375: 1030-47.